8 3/24/2015

Some journalists fire another “silver bullet” at Alzheimer’s amyloid target

The following is a guest blog post from one of our regular contributors, Alan Cassels, who is an author, journalist, and drug policy researcher with an interest in how clinical research and experience on pharmaceuticals gets translated for policy-makers, prescribers and consumers. ————————– A March 20th story in the Boston Globe. “Biogen drug offers hope for […]

2 3/23/2015

Sponsored journalist training on “precision medicine”: Zeroing in on a conflict of interest

The following is a guest post from Andrew Holtz, one of our longtime contributors, my former colleague at CNN, and a past president of the Association of Health Care Journalists.  This is at least the sixth time that we have addressed National Press Foundation workshop funding on this site. ———————— The question came from multiple […]

2 3/23/2015

Questions for TIME about its prediction of a pill to make us more compassionate

I was challenged by a fellow health care journalist to address a story by TIME.com, with this headline, “There Could Soon Be a Pill to Make Us More Compassionate.” The story reports that, in “a new study, published in the journal Current Biology…A group led by researchers at University of California Berkeley and University of California […]

5 3/19/2015

Nick Bilton blames readers for not knowing who Joseph Mercola is

The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.  The New York Times public editor Margaret Sullivan has an excellent post up about the fear-mongering cancer story that I wrote about yesterday. She acknowledges that the coverage on this story was lacking in many ways. She also notes that Nick Bilton […]

5 3/18/2015

Why is the New York Times turning to Joseph Mercola as an expert on cancer risk?

The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.  Alert reader Bahar Gholipour (@Alterwired on Twitter) pointed us to a story appearing in today’s New York Times Style section about the potential cancer risks posed by wearable technology such as the new Apple Watch. With Gary out of the office […]

8 3/18/2015

Dissecting press release puffery – Trudy Lieberman guest post

The following is a guest post by our blog contributor, Trudy Lieberman. The longer she’s been covering health care issues, the more tuned-in she seems to be about claims she sees in health care public relations. ————————— Back in 2002 Dartmouth researchers Steve Woloshin and Lisa Schwartz concluded in JAMA that press releases from medical journals […]

5 3/17/2015

The headline I wish I’d seen about the new PCSK9 cholesterol drugs

The following is a guest post by Kevin Lomangino, managing editor of HealthNewsReview.org. He tweets as @Klomangino.    “New Drugs Cut Heart Risks by One Percentage Point: Study” That’’s the headline I didn’’t see from any stories yesterday about two new cholesterol drug studies presented at the American College of Cardiology meeting. While it might sound like something […]

30 3/16/2015

Water fluoridation and ADHD: Newsweek wades into the quagmire

The following is a guest blog post by Alan Cassels, a pharmaceutical policy researcher at the University of Victoria and the author of Seeking Sickness: Medical Screening and the Misguided Hunt for Disease (Greystone, 2012). The opinions are his; you are welcome to your own. No randomized trial has ever been done to prove if adding […]

1 3/15/2015

A Bridge Over Diagnosis – James McCormack video

With the Lown Institute’s 3rd annual Right Care conference still fresh in mind from last week in San Diego, I’m pleased to re-distribute James McCormack’s latest video, “A Bridge Over Diagnosis.”   I’ve posted past McCormack parodies: Choosing Wisely will make you happy Bohemian Polypharmacy —————— Tweet Follow us on Twitter: https://twitter.com/garyschwitzer https://twitter.com/healthnewsrevu and on […]

3 3/12/2015

“Acting as though statistical significance implies truth isn’t even approximately correct” – part 3 of a series

Is a P-value of 0.05 sacrosanct? As I asked trusted sources about statistical significance, one road led clearly to Dr. Donald Berry of MD Anderson Cancer Center. He is a fellow of the American Statistical Association.  If you’ve heard his name, it may have been in the context of breast cancer.  Since 1990 he has […]

Toolkit

Tips for Understanding Studies

View More

Toolkit